These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Irreversible inhibition of the Mycobacterium tuberculosis beta-lactamase by clavulanate. Hugonnet JE, Blanchard JS. Biochemistry; 2007 Oct 30; 46(43):11998-2004. PubMed ID: 17915954 [Abstract] [Full Text] [Related]
24. Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics. Cohen KA, El-Hay T, Wyres KL, Weissbrod O, Munsamy V, Yanover C, Aharonov R, Shaham O, Conway TC, Goldschmidt Y, Bishai WR, Pym AS. EBioMedicine; 2016 Jul 30; 9():170-179. PubMed ID: 27333036 [Abstract] [Full Text] [Related]
25. Structure of GES-1 at atomic resolution: insights into the evolution of carbapenamase activity in the class A extended-spectrum beta-lactamases. Smith CA, Caccamo M, Kantardjieff KA, Vakulenko S. Acta Crystallogr D Biol Crystallogr; 2007 Sep 30; 63(Pt 9):982-92. PubMed ID: 17704567 [Abstract] [Full Text] [Related]
26. Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem. Tremblay LW, Fan F, Blanchard JS. Biochemistry; 2010 May 04; 49(17):3766-73. PubMed ID: 20353175 [Abstract] [Full Text] [Related]
32. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases. Mustafi D, Hofer JE, Huang W, Palzkill T, Makinen MW. Spectrochim Acta A Mol Biomol Spectrosc; 2004 May 04; 60(6):1279-89. PubMed ID: 15134725 [Abstract] [Full Text] [Related]
33. Structural insights into substrate recognition and product expulsion in CTX-M enzymes. Delmas J, Leyssene D, Dubois D, Birck C, Vazeille E, Robin F, Bonnet R. J Mol Biol; 2010 Jul 02; 400(1):108-20. PubMed ID: 20452359 [Abstract] [Full Text] [Related]
34. Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates. Sharma AK, Vats P. Indian J Tuberc; 2019 Jan 02; 66(1):92-98. PubMed ID: 30797291 [Abstract] [Full Text] [Related]
35. Unanticipated inhibition of the metallo-beta-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES): a crystallographic study at 1.85-A resolution. Fitzgerald PM, Wu JK, Toney JH. Biochemistry; 1998 May 12; 37(19):6791-800. PubMed ID: 9578564 [Abstract] [Full Text] [Related]
36. Crystal structure of Pseudomonas aeruginosa SPM-1 provides insights into variable zinc affinity of metallo-beta-lactamases. Murphy TA, Catto LE, Halford SE, Hadfield AT, Minor W, Walsh TR, Spencer J. J Mol Biol; 2006 Mar 31; 357(3):890-903. PubMed ID: 16460758 [Abstract] [Full Text] [Related]
38. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase. Kim JY, Jung HI, An YJ, Lee JH, Kim SJ, Jeong SH, Lee KJ, Suh PG, Lee HS, Lee SH, Cha SS. Mol Microbiol; 2006 May 31; 60(4):907-16. PubMed ID: 16677302 [Abstract] [Full Text] [Related]
39. Characterization of broad-spectrum Mycobacterium abscessus class A β-lactamase. Soroka D, Dubée V, Soulier-Escrihuela O, Cuinet G, Hugonnet JE, Gutmann L, Mainardi JL, Arthur M. J Antimicrob Chemother; 2014 Mar 31; 69(3):691-6. PubMed ID: 24132992 [Abstract] [Full Text] [Related]
40. Kinetic and Structural Characterization of the Interaction of 6-Methylidene Penem 2 with the β-Lactamase from Mycobacterium tuberculosis. Hazra S, Kurz SG, Wolff K, Nguyen L, Bonomo RA, Blanchard JS. Biochemistry; 2015 Sep 15; 54(36):5657-64. PubMed ID: 26237118 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]